Blueprint Genetics Blueprint Genetics to Analyze Biobank Samples for Rare Diseases in New Finnish Study Researchers plan to identify and sequence the exomes of 3,000 individuals from the biobank who are likely to have one of a number of rare diseases. Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders Blueprint Genetics, recently acquired by Quest Diagnostics in January, will base the 600-gene panel on its whole-exome sequencing capability. In Brief This Week: LineaRx, OncoCyte, Vela Diagnostics, CosmosID, More News items for the week of Feb. 3, 2020. Quest Diagnostics Aims to Leverage Blueprint Acquisition to Advance Genetic Testing Portfolio Premium The company expects that Blueprint's informatics capabilities in particular will improve variant interpretation and reporting across all its genetic test offerings. Quest Diagnostics Acquires Blueprint Genetics Blueprint provides 3,900 targeted single-gene and more than 200 panel tests covering 14 medical specialties, leveraging NGS and bioinformatics methods. Oct 17, 2019 BC Platforms, Blueprint Genetics Partner on Data-Driven Clinical Genetic Testing Oct 3, 2019 Blueprint Genetics to Open North American Lab as Biopharma Business Grows Premium Sep 24, 2019 Blueprint Genetics, Archimedlife to Launch Biochemical Rare Disease Testing in North America Dec 7, 2018 People in the News: Hilde Furberg, Caroline Loew, Stanley Lapidus, More Mar 13, 2018 Blueprint Genetics Updates Technology as Expansion Continues Premium Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.